Takeda Pharmaceutical (TAK) Change in Intangibles (2018 - 2026)

Takeda Pharmaceutical's Change in Intangibles history runs 9 years deep, the most recent figure standing at -$107.9 million for Q1 2026.

• On a quarterly basis, Change in Intangibles rose 62.52% year-over-year to -$107.9 million in Q1 2026; TTM through Mar 2026 was -$1.5 billion, a 61.15% decrease from a year earlier, with the FY2026 full-year figure at -$1.6 billion, down 61.67% from the prior year.
• Change in Intangibles climbed to -$107.9 million in Q1 2026 per TAK's latest filing, from -$1.2 billion in the prior quarter.
• Across five years, Change in Intangibles topped out at -$75.1 million in Q3 2024 and bottomed at -$3.1 billion in Q1 2023.
• The 5-year median for Change in Intangibles is -$187.7 million (2025), against an average of -$502.9 million.
• Across the five-year window, Change in Intangibles plunged 2108.38% in 2023 and soared 95.67% in 2024, its largest moves.
• Year by year, Change in Intangibles stood at -$121.5 million in 2022, then plunged by 67.35% to -$203.3 million in 2023, then soared by 62.58% to -$76.1 million in 2024, then plunged by 1421.71% to -$1.2 billion in 2025, then soared by 90.67% to -$107.9 million in 2026.
• Per Business Quant, the three latest TAK Change in Intangibles figures stand at -$107.9 million (Q1 2026), -$1.2 billion (Q4 2025), and -$86.4 million (Q3 2025).